Instead, it was driven by the core business and a lower tax rate. |
It is possible that pharmaceutical group stock momentum could carry (Lilly) higher, but we believe the risk/reward warrants a neutral rating. |
Seniors appear to be filling incremental prescriptions, given additional drug coverage. |
We anticipate a relief rally for pharmaceutical stocks. |